(Q52230732)

27 April 2018

title

Developmental Changes in Serum Concentrations of Desipramine and 2-Hydroxydesipramine during Treatment with Desipramine (English)

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

20 October 2022

2

J Biederman

1 reference

27 April 2018

author name string

T. E. Wilens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1644733

20 October 2022

R. J. Baldessarini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1644733

20 October 2022

P. R. Puopolo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1644733

20 October 2022

J. G. Flood

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1644733

20 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1644733

20 October 2022

publication date

1 July 1992

1 reference

27 April 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0890856709640867?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

https://api.elsevier.com/content/article/PII:S0890856709640867?httpAccept=text/plain

20 October 2022

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Journal of the American Academy of Child and Adolescent Psychiatry

20 October 2022

published in

1 reference

27 April 2018

volume

31

1 reference

27 April 2018

issue

4

1 reference

27 April 2018

page(s)

691-698

1 reference

27 April 2018

Anticonvulsant cotreatment may increase toxic metabolites of antidepressants and other psychotropic drugs.

cites work

4

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Pediatric cardiovascular effects of imipramine and desipramine

20 October 2022

5

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Sudden death in children treated with a tricyclic antidepressant

20 October 2022

6

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy

20 October 2022

7

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings

20 October 2022

8

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Desipramine hydroxylation: variability and effect of antipsychotic drugs

20 October 2022

9

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma

20 October 2022

10

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary report

20 October 2022

11

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Model for the kinetics of imipramine and its metabolites in adolescents

20 October 2022

12

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Desipramine and 2-hydroxy-desipramine pharmacokinetics in normal volunteers

20 October 2022

13

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response

20 October 2022

14

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children

20 October 2022

15

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Desipramine in the treatment of adolescents with attention deficit disorder

20 October 2022

16

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractility of the anesthetized dogs

20 October 2022

18

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Altered hydroxydesipramine concentrations in elderly depressed patients

20 October 2022

20

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Electrocardiogram changes and therapeutic desipramine and 2-hydroxy-desipramine concentrations in elderly depressives

20 October 2022

21

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Nonlinear desipramine kinetics: prevalence and importance

20 October 2022

22

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics

20 October 2022

23

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Antidepressant activity of 2-hydroxydesipramine

20 October 2022

25

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

20 October 2022

26

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Hydroxylated metabolites of tricyclic antidepressants: preclinical assessment of activity

20 October 2022

28

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Active metabolites of imipramine and desipramine in man

20 October 2022

29

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Depression in children: relationship between plasma imipramine levels and response

20 October 2022

30

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Plasma levels of imipramine and adverse effects in children

20 October 2022

31

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Imipramine in prepubertal major depressive disorders

20 October 2022

32

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Sudden death in children receiving Norpramin: a review of three reported cases and commentary

20 October 2022

35

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Heterocyclic antidepressants in children and adolescents

20 October 2022

36

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Cardiovascular effects of desipramine in children

20 October 2022

38

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

The analysis and disposition of imipramine and its active metabolites in man

20 October 2022

40

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

A potential clinical use for methylphenidate with tricyclic antidepressants.

20 October 2022

41

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Plasma 10-hydroxynortriptyline in elderly depressed patients

20 October 2022

42

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients.

20 October 2022

43

1 reference

https://api.crossref.org/works/10.1097/00004583-199207000-00017

20 October 2022

Identifiers

1 reference

27 April 2018

1 reference

27 April 2018